Challenges in Development of Nanoparticle-Based Therapeutics
Abraxis (United States) · Bristol-Myers Squibb (Switzerland)
Abstract
In recent years, nanotechnology has been increasingly applied to the area of drug development. Nanoparticle-based therapeutics can confer the ability to overcome biological barriers, effectively deliver hydrophobic drugs and biologics, and preferentially target sites of disease. However, despite these potential advantages, only a relatively small number of nanoparticle-based medicines have been approved for clinical use, with numerous challenges and hurdles at different stages of development. The complexity of nanoparticles as multi-component three dimensional constructs requires careful design and engineering, detailed orthogonal analysis methods, and reproducible scale-up and manufacturing process to achieve…
Citation impact
- FWCI
- 20.78
- Percentile
- 100%
- References
- 89
Authors
1Topics & keywords
- Context (archaeology)
- Risk analysis (engineering)
- Nanotechnology
- Process (computing)
- New product development
- Drug development
- Nanomedicine
- Computer science
- Good health and well-being